KINETICOS DISRUPTOR FUND
Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies. The Fund will focus on large, unmet medical needs in oncology, neurosciences, and rare diseases. In oncology, new approaches to solid tumors and “off the shelf” allogeneic cell therapies are immediate priorities.
Similar Organizations
Avoro Capital Advisors
Avoro Capital Advisors is a global life sciences investment firm.
BioBrit
Founded in 2012, BioBrit is a life sciences consulting and investment firm located in La Jolla, California.
HAT Technology & Innovation Fund
HAT Technology & Innovation Fund is a reserved closed-end alternative investment fund.
My Climate Journey Collective
My Climate Journey Collective is an early-stage climate tech fund.
Neo Kuma Ventures
Psychedelic Healthcare Investment Fund
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-14 | Inceptor Bio | Kineticos Disruptor Fund investment in Seed Round - Inceptor Bio | 26 M USD |
| 2020-05-28 | Promaxo | Kineticos Disruptor Fund investment in Series B - Promaxo | 10.97 M USD |